Shah Vinay has filed 3 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 9000 shares of ADIAL PHARMACEUTICALS, INC. ($ADIL) on May 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Shah Vinay | Chief Financial Officer | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 6,539,760 | 9999.99% | 0.14% |
| Nov. 16, 2024 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Shah Vinay | Chief Financial Officer | A | Stock Option | 40000 | $0.00 | 40,000.0000 | 5,835,682 | 9999.99% | 0.69% |
| Jan. 29, 2024 | Virpax Pharmaceuticals, Inc. | $VRPX | Shah Vinay | Chief Financial Officer | A | Stock Option (right to buy) | 112000 | $0.00 | 112,000.0000 | 0 | 9999.99% | 0.00% |